Skip to main content

Table 3 Associations between generalised and institutional trust in wave 2 (age 17–18) and depression and anxiety symptoms in wave 3 (age 20–21). Results from binary logistic and linear regression models. n = 2,668

From: Trust in adolescence and depression and anxiety symptoms in young adulthood: findings from a Swedish cohort

 

Depression symptoms (PHQ-2, cutoff ≥ 3), wave 3

 

Crudea

Model 1b

Model 2c

Model 3d

 

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

Generalised trust, wave 2

0.49***

0.41, 0.58

0.64***

0.53, 0.77

  

0.66***

0.54, 0.80

Institutional trust, wave 2

0.60***

0.50, 0.71

  

0.79*

0.65, 0.96

0.92

0.75, 1.13

 

Anxiety symptoms (GAD-2, cutoff ≥ 3), wave 3

 

Crudea

Model 1b

Model 2c

Model 3d

 

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

Generalised trust, wave 2

0.57***

0.48, 0.67

0.72***

0.60, 0.87

  

0.74**

0.61, 0.91

Institutional trust, wave 2

0.66***

0.56, 0.79

  

0.83*

0.69, 1.00

0.93

0.76, 1.13

 

Depression and anxiety symptoms (PHQ-4, scale 0–12), wave 3

 

Crudea

Model 1b

Model 2c

Model 3d

 

b

95% CI

b

95% CI

b

95% CI

b

95% CI

Generalised trust, wave 2

-1.19***

-1.40, -0.97

-0.73***

-0.94, -0.51

  

-0.71***

-0.95, -0.48

Institutional trust, wave 2

-0.77***

-1.00, -0.53

  

-0.30*

-0.54, -0.06

-0.04

-0.30, 0.22

  1. *** p < 0.001 **p < 0.01 *p < 0.05
  2. a Includes one variable at a time, controlling for gender
  3. b Includes generalised trust (measured in wave 2); gender, parental education, parental country of birth (measured in wave 1); and upper secondary programme, medication for depression and anxiety, and psychosomatic complaints (measured in wave 2)
  4. c Includes institutional trust (measured in wave 2); gender, parental education, parental country of birth (measured in wave 1); and upper secondary programme, medication for depression and anxiety, and psychosomatic complaints (measured in wave 2)
  5. d Includes generalised and institutional trust (measured in wave 2); gender, parental education, parental country of birth (measured in wave 1); and upper secondary programme, medication for depression and anxiety, and psychosomatic complaints (measured in wave 2)